Clinical Trial Update: Concurrent Cisplatin Chemoradiation With or Without Capecitabine as Adjuvant Chemotherapy in Local Advanced High Risk Nasopharyngeal Carcinoma: Randomized Control Clinical Trial [Phase 3]

View source ↗

Summary

Phase 3 randomized trial evaluating concurrent cisplatin chemoradiation with or without capecitabine as adjuvant therapy for local advanced high-risk nasopharyn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• CISPLATIN (cisplatin)
• Capecitabine (capecitabine)

Snippet

Sponsor: Zhao Chong | Conditions: Local Advanced High Risk Nasopharyngeal Carcinoma | Phase 3 | Status: COMPLETED